A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma

• Main Authors: Zhenzhen Chu (Author), Baohuan Zhang (Author), Xuxuan Zhou (Author), Hui Yuan (Author), Chongqing Gao (Author), Lihao Liu (Author), Yang Xiao (Author), Jichun Zhang (Author), Jian Hong (Author), Junjie Liang (Author), Dong Chen (Author), Nan Yao (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pemigatinib, a pan-FGFR inhibitor, is approved to treat intrahepatic cholangiocarcinoma (ICC) harboring FGFR2 fusion mutations. Improving its targeting of FGFR2 fusions remains an unmet clinical need due to its pan selectivity and resistance. Here, we report a cholesterol-conjugated DNA/RNA heterodu...